1. Cefazolin is non-inferior.
2. Less AKI with Cefazolin.
#ESCMIDGlobal
1. Cefazolin is non-inferior.
2. Less AKI with Cefazolin.
#ESCMIDGlobal
🔥SNAP RCT🔥The largest RCT 2 date in SA bactermia
N:1341
Cefazolin Vs ASPs ((flu)cloxacillin) for MSSA bacteremia
Cefazolin is non-inferior (90d mortality)& less AKI than ASPs
A practice-changer RCT that must change the guidelines
#ESCMIDGlobal #IDSky
🔥SNAP RCT🔥The largest RCT 2 date in SA bactermia
N:1341
Cefazolin Vs ASPs ((flu)cloxacillin) for MSSA bacteremia
Cefazolin is non-inferior (90d mortality)& less AKI than ASPs
A practice-changer RCT that must change the guidelines
#ESCMIDGlobal #IDSky
Cloxacillin versus cefazolin for MSSA Bacteraemia
Cefazolin has a non-inferior efficacy regarding mortality, microbiological or clinical endpoints and was associated with a lower rate of serious adverse events #IDSky
www.thelancet.com/journals/lan...
Cloxacillin versus cefazolin for MSSA Bacteraemia
Cefazolin has a non-inferior efficacy regarding mortality, microbiological or clinical endpoints and was associated with a lower rate of serious adverse events #IDSky
www.thelancet.com/journals/lan...
Writing papers:
Cefazolin (MSSA) and penicillin (PSSA) vs (flu)clox
Recruiting:
Adj clinda vs not (all)
Adj cefazolin vs not (MRSA)
Oral switch vs IV (all)
Cefazolin +/- Erta/Placebo (MSSA)
Dapto vs Vanco (MRSA)
Coming "soon":
Rifampin vs. none for PVIE (all)
Ref: Dr.Lee #idsky
Writing papers:
Cefazolin (MSSA) and penicillin (PSSA) vs (flu)clox
Recruiting:
Adj clinda vs not (all)
Adj cefazolin vs not (MRSA)
Oral switch vs IV (all)
Cefazolin +/- Erta/Placebo (MSSA)
Dapto vs Vanco (MRSA)
Coming "soon":
Rifampin vs. none for PVIE (all)
Ref: Dr.Lee #idsky
@connorprosty.bsky.social @seanong.bsky.social &c
Cefaz more effective, safer #idsky
www.clinicalmicrobiologyandinfection.com/article/S119... 🔓
@connorprosty.bsky.social @seanong.bsky.social &c
Cefaz more effective, safer #idsky
www.clinicalmicrobiologyandinfection.com/article/S119... 🔓
fluclox caused more acute kidney injury than cefazolin; early mortality favored cefazolin
Absolutely Herculean effort by the entire global trial team and practice changing data #teamcefazolin
fluclox caused more acute kidney injury than cefazolin; early mortality favored cefazolin
Absolutely Herculean effort by the entire global trial team and practice changing data #teamcefazolin
www.nejm.org/doi/full/10....
Cefazolin is already the new standard!
#IDsky #AMSsky
www.nejm.org/doi/full/10....
Cefazolin is already the new standard!
#IDsky #AMSsky
SNAP RCT + CloCeBa RCT
Cefazolin is non-inferior to Anti Staphylococcal Penicillins (ASPs) for treatment of MSSA bactremia and causes less AKI and should be 1st line therapy #idsky #ESCMIDGlobal2026
SNAP RCT + CloCeBa RCT
Cefazolin is non-inferior to Anti Staphylococcal Penicillins (ASPs) for treatment of MSSA bactremia and causes less AKI and should be 1st line therapy #idsky #ESCMIDGlobal2026
Cefazolin was the champion for MSSA
🏆 Less nephrotoxicity than flucoxacillin
🏆 Reduced early mortality
Not published but I think the answer is clear:
Cefazolin now generally 1st line tx for MSSA
"Innoculum effect" with nafcillin= debunked
Updated IBCC (#1/2) #EMIMCC
Cefazolin was the champion for MSSA
🏆 Less nephrotoxicity than flucoxacillin
🏆 Reduced early mortality
Not published but I think the answer is clear:
Cefazolin now generally 1st line tx for MSSA
"Innoculum effect" with nafcillin= debunked
Updated IBCC (#1/2) #EMIMCC
SNAP RCT
In patients with MSSA bacteremia, cefazolin was noninferior to flucloxacillin or cloxacillin with respect to 90-day mortality and was associated with a lower incidence of acute kidney injury. #idsky
www.nejm.org/doi/full/10....
SNAP RCT
In patients with MSSA bacteremia, cefazolin was noninferior to flucloxacillin or cloxacillin with respect to 90-day mortality and was associated with a lower incidence of acute kidney injury. #idsky
www.nejm.org/doi/full/10....
SNAP platform RCT| Adjunctive Clindamycin in S.aureus bacteraemia
❌ No mortality benefit
90d mortality:16.9% vs 15.2% aOR 1.16 (CrI cross 1)
📊PPSup(~7%)→Futility threshold reached
⚠️ICU subgp:numerically worse with clinda
⚖️CDAD:no # (~2%)😯
#ESCMIDGlobal2026 #idsky
I got cefazolin!
I got cefazolin!
Flucloxacillin z.B.: 2g alle 4 h oder Cefazolin 3x2g
Therapiedauer:
Unkompliziert: 2 Wochen
Kompliziert: 4-6 Wochen ab 1. negativer Blutkultur
#FOAMed #ABS #ICU
30 observational studies( SNAP & CloCeBa not included)
N: 3869
Cefazolin versus Antistaphylococcal Penicillins for the Treatment of MSSA Bacteremia #idsky
www.clinicalmicrobiologyandinfection.com/article/S119...
30 observational studies( SNAP & CloCeBa not included)
N: 3869
Cefazolin versus Antistaphylococcal Penicillins for the Treatment of MSSA Bacteremia #idsky
www.clinicalmicrobiologyandinfection.com/article/S119...
Cefazolin manufacturers are gonna have to really step up after this (still on shortage restrictions in 🇬🇧 😢)
RIP fluclox 🪦
@gurujosh.bsky.social gave an excellent talk 🥁
#ESCMIDGlobal
Cefazolin manufacturers are gonna have to really step up after this (still on shortage restrictions in 🇬🇧 😢)
RIP fluclox 🪦
@gurujosh.bsky.social gave an excellent talk 🥁
#ESCMIDGlobal
SNAP RCT
In patients with MSSA bacteremia, cefazolin was noninferior to flucloxacillin or cloxacillin with respect to 90-day mortality and was associated with a lower incidence of acute kidney injury. #idsky
www.nejm.org/doi/full/10....
2. ?
3. Ceftriaxone
4. Cefepime
5. Ceftaroline
2. ?
3. Ceftriaxone
4. Cefepime
5. Ceftaroline
Cefazolin is non-inferior to Fluclox for MSSA-BSI &causes less AKI
Penicillin is non-inferior to Fluclox for PSSA-B
Adjunctive clindamycin did not reduce 90-day mortality in SAB
Ongoing:
Vanco+cefazolin in MRSA BSI
Erta/cefaz SAB
Early oral switch
PET CT
#ESCMIDGlobal2026 #idsky
Cefazolin is non-inferior to Fluclox for MSSA-BSI &causes less AKI
Penicillin is non-inferior to Fluclox for PSSA-B
Adjunctive clindamycin did not reduce 90-day mortality in SAB
Ongoing:
Vanco+cefazolin in MRSA BSI
Erta/cefaz SAB
Early oral switch
PET CT
#ESCMIDGlobal2026 #idsky